Ray Snyder

Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

Henning T. Mouridsen, Mikhail Gershanovich, Yan Sun et al. · Journal of Clinical Oncology · 2001 · 1K citations · Full text

Medicine, Oncology, Pharmacology +17

Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer

Alan S. Coates, Val Gebski, James F. Bishop et al. · New England Journal of Medicine · 1987 · 538 citations

Medicine, Oncology, Pharmacology +15

Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience

Gilles Berclaz, S. Li, Karen N. Price et al. · Annals of Oncology · 2004 · 260 citations · Full text

Medicine, Oncology, Surgery +9

Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

M. D. Green, Prudence A. Francis, Val Gebski et al. · Annals of Oncology · 2009 · 63 citations · Full text

Medicine, Oncology, Pharmacology +12

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

Stefan Aebi, Zijie Sun, Danielle Braun et al. · Annals of Oncology · 2011 · 55 citations · Full text

Medicine, Clinical Sciences, Oncology +11